Deadline for applications 27 February 2015 17:00 CET. Download PDF-version
EVI has an exciting career opportunity for junior and motivated individual to join the organisation in an eighteen month full time position as Vaccine Management Assistant (VMA) for a phase I vaccine clinical trial.
With reference to the updated Malaria Vaccine Technology Roadmap, WHO has published its preferred product characteristics for malaria vaccine.
WHO Preferred Product Characteristics for Malaria Vaccines (WHO/IVB/14.09)
European Research Infrastructures for Poverty Related Diseases (EURIPRED) has announced a seond call for application for TransNational Access Services. Deadline 27 February 2015
Epidemiological evaluation of vaccines: efficacy, safety and policy
The overall aim of this short course is to provide an understanding of the methods used in the evaluation of vaccines, from early human trials through to assessment of population impact and policy.
Almac Group, the contract development and manufacturing organization, today announced its key role in preparing and delivering one of the longest synthetically produced protein fragment to be used as a vaccine in a phase I clinical trial for malaria.
- 1 of 17